A randomized clinical trial using ATG Fresenius or ATG Merieux as induction therapy in kidney transplantation.
Norrby
J
J
Department of Surgery, Sahlgrenska University Hospital, Göteborg, Sweden.
Olausson
M
M
D000818:Animals; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D011817:Rabbits
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents